---
title: "Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280469763.md"
description: "Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025"
datetime: "2026-03-25T12:10:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280469763.md)
  - [en](https://longbridge.com/en/news/280469763.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280469763.md)
generator: "portal-rs"
---

# Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025

Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025

### Related Stocks

- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [301103.CN](https://longbridge.com/en/quote/301103.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [06622.HK](https://longbridge.com/en/quote/06622.HK.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)

## Related News & Research

- [Zhaoke Ophthalmology signs exclusive distribution deal with Pharmentum Biopharma for epinastine eye drops in China](https://longbridge.com/en/news/295637204.md)
- [Zhaoke Ophthalmology says Macau regulator approves presbyopia eye drop YUVEZZI](https://longbridge.com/en/news/293159759.md)
- [Zhaoke Ophthalmology Wins Boao Approval for First Innovative Presbyopia Drug in China](https://longbridge.com/en/news/291876097.md)
- [Zhaoke Ophthalmology Shareholders Approve All Resolutions at 2026 AGM](https://longbridge.com/en/news/286577328.md)
- [Zhaoke Ophthalmology’s Myopia Drug NVK002 Accepted for Australian TGA Evaluation](https://longbridge.com/en/news/289729878.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**